Document Type
Article
Publication Date
9-2014
Digital Object Identifier (DOI)
http://dx.doi.org/10.1148/radiol.14110885
Related Content
Case 213: Primary Splenic Angiosarcoma, published in Radiology, v. 274, no. 1, p. 298-303, DOI: http://dx.doi.org/10.1148/radiol.14110919
Also available in UKnowledge: http://uknowledge.uky.edu/radiology_facpub/4/
Repository Citation
Krol, John J.; Krol, Vera V.; Dawkins, Adrian; and Ganesh, Halemane S., "Case 213" (2014). Radiology Faculty Publications. 3.
https://uknowledge.uky.edu/radiology_facpub/3
Fig. 1.ppt-2015.12.21_13.15.00.566.ppt (118 kB)
Figure 1: Axial T1-weighted (repetition time msec/echo time msec, 400/17; 5-mm section thickness) contrast-enhanced MR image of the brain (10 mL of gadopentetate dimeglumine administered intravenously over 15 seconds, Magnevist; Bayer Healthcare Pharmaceuticals, Leverkusen, Germany).
Figure 2.ppt-2015.12.21_13.16.02.872.ppt (75 kB)
Figure 2: Transverse gray-scale US image of the upper abdomen.
Figure 3.ppt-2015.12.21_13.16.10.797.ppt (88 kB)
Figure 3: Axial contrast-enhanced CT image of the chest acquired during the arterial phase (80 mL of iohexol 300 administered at a rate of 4 mL/sec, Omnipaque 300; GE Healthcare, Milwaukee, Wis).
Figure 4a.ppt-2015.12.21_13.16.23.979.ppt (115 kB)
Figure 4a: (a, b) Axial contrast-enhanced CT images of the liver during the arterial phase (80 mL of iohexol 300 administered at a rate of 4 mL/sec).
Figure 4b.ppt-2015.12.21_13.16.31.919.ppt (126 kB)
Figure 4b: (a, b) Axial contrast-enhanced CT images of the liver during the arterial phase (80 mL of iohexol 300 administered at a rate of 4 mL/sec).
Figure 5.ppt-2015.12.21_13.16.40.328.ppt (98 kB)
Figure 5: Coronal T2-weighted (900/78, 6-mm section thickness) ultrafast spin-echo MR image of the abdomen (Symphony; Siemens Medical Systems, Erlangen, Germany).
Figure 6a.ppt-2015.12.21_13.16.51.373.ppt (93 kB)
Figure 6a: Axial T1-weighted (4.3/2; 2-mm section thickness) dynamic contrast-enhanced ultrafast gradient-echo MR images of the abdomen (10 mL of gadopentetate dimeglumine) obtained during the (a) early and (b) late arterial phases.
Figure 6b.ppt-2015.12.21_13.17.18.95.ppt (90 kB)
Figure 6b: Axial T1-weighted (4.3/2; 2-mm section thickness) dynamic contrast-enhanced ultrafast gradient-echo MR images of the abdomen (10 mL of gadopentetate dimeglumine) obtained during the (a) early and (b) late arterial phases.
Figure 7.ppt-2015.12.21_13.17.54.147.ppt (124 kB)
Figure 7: Unenhanced axial CT image of the head at the time of acute mental status changes and clinical deterioration.
Figure 1: Axial T1-weighted (repetition time msec/echo time msec, 400/17; 5-mm section thickness) contrast-enhanced MR image of the brain (10 mL of gadopentetate dimeglumine administered intravenously over 15 seconds, Magnevist; Bayer Healthcare Pharmaceuticals, Leverkusen, Germany).
Figure 2.ppt-2015.12.21_13.16.02.872.ppt (75 kB)
Figure 2: Transverse gray-scale US image of the upper abdomen.
Figure 3.ppt-2015.12.21_13.16.10.797.ppt (88 kB)
Figure 3: Axial contrast-enhanced CT image of the chest acquired during the arterial phase (80 mL of iohexol 300 administered at a rate of 4 mL/sec, Omnipaque 300; GE Healthcare, Milwaukee, Wis).
Figure 4a.ppt-2015.12.21_13.16.23.979.ppt (115 kB)
Figure 4a: (a, b) Axial contrast-enhanced CT images of the liver during the arterial phase (80 mL of iohexol 300 administered at a rate of 4 mL/sec).
Figure 4b.ppt-2015.12.21_13.16.31.919.ppt (126 kB)
Figure 4b: (a, b) Axial contrast-enhanced CT images of the liver during the arterial phase (80 mL of iohexol 300 administered at a rate of 4 mL/sec).
Figure 5.ppt-2015.12.21_13.16.40.328.ppt (98 kB)
Figure 5: Coronal T2-weighted (900/78, 6-mm section thickness) ultrafast spin-echo MR image of the abdomen (Symphony; Siemens Medical Systems, Erlangen, Germany).
Figure 6a.ppt-2015.12.21_13.16.51.373.ppt (93 kB)
Figure 6a: Axial T1-weighted (4.3/2; 2-mm section thickness) dynamic contrast-enhanced ultrafast gradient-echo MR images of the abdomen (10 mL of gadopentetate dimeglumine) obtained during the (a) early and (b) late arterial phases.
Figure 6b.ppt-2015.12.21_13.17.18.95.ppt (90 kB)
Figure 6b: Axial T1-weighted (4.3/2; 2-mm section thickness) dynamic contrast-enhanced ultrafast gradient-echo MR images of the abdomen (10 mL of gadopentetate dimeglumine) obtained during the (a) early and (b) late arterial phases.
Figure 7.ppt-2015.12.21_13.17.54.147.ppt (124 kB)
Figure 7: Unenhanced axial CT image of the head at the time of acute mental status changes and clinical deterioration.
Notes/Citation Information
Published in Radiology, v. 272, no. 3, p. 911-913.
© RSNA, 2014
The copyright holders have granted the permission for posting the article here.